CORRECTING AND REPLACING: Alliqua, Inc. Acquires Exclusive License to Antimicrobial Wound Care Products from Noble Biomaterials, Inc.
Alliqua, Inc. Acquires Exclusive License to Antimicrobial Wound Care Products From Noble Biomaterials, Inc.
Alliqua, Inc. Expands Patent Portfolio for Transdermal Drug Delivery Platform
Alliqua, Inc. Announces Preparation of IND for PHN Patch
Alliqua, Inc. Files Provisional Patent in the U.S. for Transdermal Delivery System
Alliqua Successfully Completes Next Milestone in Transdermal Pain Patch Development
Alliqua to Announce Results of Initial Transdermal Pain Patch In Vitro Study; Results to be Released Monday
Frost Gamma Investments Trust Makes Strategic Investment in Alliqua, Inc.
Alliqua Announces the Successful Completion of Its Initial Study for the Transdermal Pain Patch
